Evidence map›Paper›PMID 39752158›Full record

ArticleJAMA network open2025

Factors in Initial Anticoagulation Choice in Hospitalized Patients With Pulmonary Embolism.

William B Stubblefield, Ron Helderman, Natalie Strokes, Colin F Greineder, Geoffrey D Barnes, David R Vinson, Lauren M Westafer

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. The Thromboembolism Heparinization and AntithrombiN Observational Study (THANOS-1).Research and practice in thrombosis and haemostasis · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

William B StubblefieldDepartment of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Ron HeldermanDepartment of Emergency Medicine, The University of Texas Southwestern Medical Center, Dallas.
Natalie StrokesDepartment of Emergency Medicine, University of Massachusetts Chan Medical School-Baystate, Springfield.
Colin F GreinederDepartment of Emergency Medicine, University of Michigan, Ann Arbor.
Geoffrey D BarnesFrankel Cardiovascular Center, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
David R VinsonDivision of Research, Kaiser Permanente Northern California, Pleasanton.
Lauren M WestaferDepartment of Emergency Medicine, University of Massachusetts Chan Medical School-Baystate, Springfield.

Funding

De-Implementation of Low Value Imaging in Pulmonary Embolism (DELVE PE)K23HL155895 · NHLBI · BAYSTATE MEDICAL CENTER, INC. · PI WESTAFER, LAUREN · 2021 to 2025
$872k
NHLBI NIH HHS K23 HL155895
6 · The paper itself

Abstract

Importance: Despite guideline recommendations to use low-molecular-weight heparins (LMWHs) or direct oral anticoagulants in the treatment of most patients with acute pulmonary embolism (PE), US-based studies have found increasing use of unfractionated heparin (UFH) in hospitalized patients. Objective: To identify barriers and facilitators of guideline-concordant anticoagulation in patients hospitalized with acute PE. Design, Setting, and Participants: This qualitative study conducted semistructured interviews from February 1 to June 3, 2024, that were recorded, transcribed, and analyzed in an iterative process using reflexive thematic analysis. Interview participants were physicians in emergency medicine, hospital medicine (hospitalist), interventional cardiology, and interventional radiology. Participants were recruited using maximum variation sampling targeting UFH-dominant vs LMWH-dominant approaches in hospitalized patients with acute PE. We triangulated results with a group of interventional cardiologists and radiologists (interventionalists). Main Outcomes and Measures: Common themes and factors associated with anticoagulant selection for hospitalized patients with acute PE. Reflexive thematic analysis was used to identify these themes and factors. Results: Of the 46 interviewees (median [IQR] age, 43 [36-50] years; 33 who identified as men [71.7%]), 25 (54.3%) were emergency physicians, 17 (37.0%) were hospitalists, and 4 (8.7%) were interventionalists. Each interview lasted a median (IQR) of 29 (25-32) minutes. Prominent themes associated with anticoagulant selection included agnosticism regarding choice of anticoagulant, the inertia of learned practice, and therapeutic momentum after anticoagulation initiation. Institutional culture and support were factors associated with choice of the dominant anticoagulation strategy. Additionally, factors associated with UFH use were fear of decompensation and misperceptions regarding the pharmacology of anticoagulants and catheter-directed treatments. Conclusions and Relevance: In this qualitative study, physicians across a spectrum of specialties and geographical settings reported common barriers and facilitators to the use of guideline-concordant anticoagulation in patients hospitalized with acute PE, particularly agnosticism regarding choice of anticoagulant, inertia of learned practice, therapeutic momentum after anticoagulation initiation, and institutional culture and support. Future implementation efforts may consider targeting these domains.

Indexed as

AnticoagulantsHospitalizationPulmonary EmbolismQualitative ResearchAdultFemaleGuideline AdherenceHeparinHeparin, Low-Molecular-WeightHumansMaleMiddle AgedPractice Patterns, Physicians'AnticoagulantsHeparinHeparin, Low-Molecular-Weight

Identifiers

PMID39752158
PMCPMC11699532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.